Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

LESSONS LEARNED. Panitumumab shows activity in terms of disease control rate and preventing disease progression but not for tumor shrinkage in head and neck squamous cell cancer for second‐line treatment. Epidermal growth factor receptor (EGFR) copy number gain, a property of tumor cells that theore...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncologist
Hauptverfasser: Siano, Marco, Molinari, Francesca, Martin, Vittoria, Mach, Nicolas, Früh, Martin, Freguia, Stefania, Corradino, Irene, Ghielmini, Michele, Frattini, Milo, Espeli, Vittoria
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2017
Schlagworte:
Clinical Trial Results
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5507653/
https://ncbi.nlm.nih.gov/pubmed/28592616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0069
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge